Massachusetts Financial Services
DAWN

Massachusetts Financial Services’s Day One Biopharmaceuticals DAWN Stock Holding History

Massachusetts Financial Services’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-147,012
Closed -$3.15M – 1020
2026
Q1 		$3.15M Sell
147,012
-3,913
-3% -$55.1K ﹤0.01% 785
2025
Q4 		$1.41M Buy
+150,925
New +$1.26M ﹤0.01% 815

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Massachusetts Financial Services's DAWN Position: Q2 2026 in Review

Massachusetts Financial Services sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 147,012 shares — an estimated $3.15M sold.

Massachusetts Financial Services first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $3.15M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Massachusetts Financial Services reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 147,012 Day One Biopharmaceuticals shares in Q2 2026, an estimated $3.15M.
  • Massachusetts Financial Services first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Massachusetts Financial Services's Day One Biopharmaceuticals position peaked at $3.15M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.